Skip to main content
Equibles
INFU logo

INFU · InfuSystem Holdings, Inc · Metrics

Track INFU — free

Use INFU with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research INFU.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$12.12 -0.08 (-0.66%) At close · Sep 10
Russell 2000 member Rebalance outlook locked
Market Cap
$241.40M
Shares
19.92M

INFU metrics

91 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$12.12
Market cap
$241.40M

Price action

20 metrics
Price change (1W)
+0.5%
Price change (30D)
-2.1%
Price change (3M)
+37.4%
Price change (6M)
+27.0%
Price change (YTD)
+36.0%
Price change (1Y)
+17.1%
Trailing year
Price change (5Y)
-11.2%
52-week high
$12.49
52-week low
$7.42
Change from 52-week high
-2.3%
Change from 52-week low
+64.4%
Annualized volatility
58.5%
Annualized volatility (3M)
80.7%
Beta
1.3
RSI (14D)
59.8
Price vs SMA 50
+12.5%
Price vs SMA 200
+27.8%
Avg volume (3M)
187,928
Relative volume
0.9
Average dollar volume
$1.95M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
19.92M

Valuation

12 metrics
P / E (TTM)
30.5
Trailing earnings · reciprocal yield 3.3%
PEG ratio
1.2
EV / revenue
1.8×
reciprocal yield 55.3%
EV / EBITDA
9.8×
reciprocal yield 10.2%
EV / EBIT
19.5×
reciprocal yield 5.1%
P / sales
1.7×
reciprocal yield 59.8%
P / book
4.1
reciprocal yield 24.7%
FCF yield
9.6%
TTM · current market cap
Buyback yield
3.3%
P / FCF
10.5
reciprocal yield 9.6%
P / operating cash flow
10.3
reciprocal yield 9.8%
Earnings yield
3.6%

Historical valuation

8 metrics
P / E historical average (3Y)
168.3×
reciprocal yield 0.6%
P / E historical average (5Y)
219.8×
reciprocal yield 0.5%
EV / revenue historical average (3Y)
1.5×
reciprocal yield 68.3%
EV / revenue historical average (5Y)
1.8×
reciprocal yield 54.5%
EV / EBIT historical average (3Y)
34.4×
reciprocal yield 2.9%
EV / EBIT historical average (5Y)
69.4×
reciprocal yield 1.4%
EV / EBITDA historical average (3Y)
10.0×
reciprocal yield 10.0%
EV / EBITDA historical average (5Y)
12.0×
reciprocal yield 8.3%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
3.3%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-04

Profitability

9 metrics
Gross margin
57.5%
Operating margin
9.3%
Trailing 12 months
Net margin
6.0%
Gross profit (TTM)
$82.35M
Operating profit (TTM)
$13.27M
Net income (TTM)
$8.54M
Trailing 12 months
Diluted EPS (TTM)
$0.40
FCF margin
16.0%
Effective tax rate
30.0%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$2.84

Growth

11 metrics
Revenue growth YoY
+2.6%
Year over year
Net income growth YoY
+24.3%
Revenue (TTM)
$143.34M
Trailing 12 months
EPS growth YoY
+25.0%
Shares change YoY
-0.6%
Year over year · fewer shares
Revenue CAGR (3Y)
+9.3%
Revenue CAGR (5Y)
+8.1%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
-17.3%
FCF CAGR (3Y)
+13.0%
FCF CAGR (5Y)
+4.4%

Quality

14 metrics
Return on equity
14.4%
Return on assets
8.7%
Debt / equity
0.3
Current ratio
2.5
EBITDA (TTM)
$26.33M
Free cash flow (TTM)
$22.91M
Quick ratio
2.1
Interest coverage
12.1
Net debt / EBITDA
0.7
Return on invested capital
11.8%
Trailing 12 months
Net cash
−$19.46M
Latest balance sheet
Cash & equivalents
$964,000
Total assets
$97.70M
Total debt
$20.42M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$23.37M
Capital expenditures (TTM)
$460,000
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$5.07M
R&D / revenue
—
Stock compensation / revenue
3.5%

Ownership (13F)

3 metrics
13F filers
99
13F filer change QoQ
+3
Institutional ownership
75.5%

Short interest

3 metrics
Short interest
3.8%
Latest settlement · 8.4 days to cover
Days to cover
8.4d
Short-squeeze score
70 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1337013 CUSIP 45685K102 13F (30d) 64 filings 64 filers Visit website Investor relations